Dou, Jun <br/><br/>
Study of immunotherapy of murine myeloma by an IL-21-based tumor vaccine in BALB/C mice.  [electronic resource] 

 -  Cancer biology & therapy  Dec 2007 
 - 1871-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.6.12.4960  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis<br/>B7-1 Antigen--biosynthesis<br/>Cancer Vaccines--therapeutic use<br/>Chemokine CXCL11--biosynthesis<br/>Histocompatibility Antigens Class I--biosynthesis<br/>Immunotherapy<br/>Interferon-gamma--metabolism<br/>Interleukin-4--biosynthesis<br/>Interleukins--biosynthesis<br/>Killer Cells, Natural--immunology<br/>Lymphocytes, Tumor-Infiltrating--pathology<br/>Mice<br/>Mice, Inbred BALB C<br/>Multiple Myeloma--immunology<br/>Neoplasm Proteins--biosynthesis<br/>Random Allocation<br/>Receptors, CXCR3--biosynthesis<br/>Specific Pathogen-Free Organisms<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Up-Regulation<br/>Vaccines, Synthetic--immunology<br/>Interleukin-21